Basic Information
| RNALocate ID: | RLID:11003295 |
| RNA Symbol: | hsa-miR-608 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-608 |
| RNA ID: | miRBase:MIMAT0003276 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 18589210 |
| Tissue/Cell Line: | Primary ovarian tumor cells|Serum |
| Method: | MACS|Microarray |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11001371 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11004028 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-608 | Oral squamous cell carcinoma | MNDR-E-MI-62948 |
| MNDR | hsa-miR-608 | Lymphoma | MNDR-E-MI-62949 |
| MNDR | hsa-miR-608 | Estrogen-receptor positive breast cancer | MNDR-E-MI-62950 |
| MNDR | hsa-miR-608 | Estrogen-receptor negative breast cancer | MNDR-E-MI-62951 |
| MNDR | hsa-miR-608 | Progesterone-receptor positive breast cancer | MNDR-E-MI-62952 |
| MNDR | hsa-miR-608 | Progesterone-receptor negative breast cancer | MNDR-E-MI-62953 |
| MNDR | hsa-miR-608 | Her2-receptor positive breast cancer | MNDR-E-MI-62954 |
| MNDR | hsa-mir-608 | Lupus nephritis | MNDR-E-MI-62955 |
| MNDR | hsa-mir-608 | Colorectal carcinoma | MNDR-E-MI-62956 |
| MNDR | hsa-miR-608 | Gastric cancer | MNDR-E-MI-62957 |
| MNDR | hsa-miR-608 | Parkinson disease | MNDR-E-MI-62958 |
| MNDR | hsa-miR-608 | Breast cancer | MNDR-E-MI-62959 |
| MNDR | hsa-mir-608 | Breast cancer | MNDR-E-MI-62960 |
| MNDR | hsa-miR-608 | Pancreatic cancer | MNDR-E-MI-62961 |
| MNDR | hsa-miR-608 | Melanoma | MNDR-E-MI-62962 |
| MNDR | hsa-miR-608 | Colon cancer | MNDR-E-MI-62963 |
| MNDR | hsa-mir-608 | Colon cancer | MNDR-E-MI-62964 |
| MNDR | hsa-mir-608 | Ovarian cancer | MNDR-E-MI-62965 |
| MNDR | hsa-mir-608 | Glioblastoma | MNDR-E-MI-62966 |
| MNDR | hsa-miR-608 | Malignant glioma | MNDR-E-MI-62967 |
| MNDR | hsa-mir-608 | Chordoma | MNDR-E-MI-62968 |
| MNDR | hsa-miR-608 | Pancreatic ductal adenocarcinoma | MNDR-E-MI-62969 |
| MNDR | hsa-miR-608 | Meningioma | MNDR-E-MI-62970 |
| MNDR | hsa-miR-608 | Liver cancer | MNDR-E-MI-62971 |
| MNDR | hsa-mir-608 | Adenocarcinoma lung | MNDR-E-MI-62972 |
| MNDR | hsa-miR-608 | Cholangiocarcinoma | MNDR-E-MI-62973 |
| MNDR | hsa-mir-608 | Hepatocellular carcinoma | MNDR-E-MI-62974 |
| MNDR | hsa-miR-608 | Hepatocellular carcinoma | MNDR-E-MI-62975 |
| MNDR | hsa-miR-608 | Embryonal cancer | MNDR-E-MI-62976 |
| MNDR | hsa-mir-608 | Kaposi sarcoma | MNDR-E-MI-62977 |
| MNDR | hsa-mir-608 | Systemic lupus erythematosus | MNDR-E-MI-62978 |
| MNDR | hsa-miR-608 | Colorectal cancer | MNDR-E-MI-62979 |
| MNDR | hsa-mir-608 | Colorectal cancer | MNDR-E-MI-62980 |
| MNDR | hsa-mir-608 | Carcinoma nasopharyngeal | MNDR-E-MI-62981 |
| MNDR | hsa-miR-608 | Nasopharynx carcinoma | MNDR-E-MI-62982 |
| MNDR | hsa-miR-608 | Multiple myeloma | MNDR-E-MI-62983 |
| MNDR | hsa-mir-608 | Lupus vulgaris | MNDR-E-MI-62984 |
| MNDR | hsa-miR-608 | Nasopharyngeal cancer | MNDR-E-MI-62985 |
| MNDR | hsa-miR-608 | Breast cancer her3+ negative | MNDR-E-MI-62986 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2L1 | Homo sapiens | RR00219232 |
TOP